| Brand | Ibrunitib |
| Pack Size | 1 Bottle |
| Dosage Form | Capsule |
| Packaging Type | Bottle |
| Indications | CLL/SLL |
Ibrutinib Capsule is a prescription anticancer medicine used to treat specific blood cancers such as chronic lymphocytic leukemia, mantle cell lymphoma, and Waldenström’s macroglobulinemia. It belongs to the class of Bruton’s tyrosine kinase inhibitors and works by blocking signals that help cancer cells grow and survive. The capsule is taken orally, usually once daily, as advised by an oncologist. Ibrutinib helps control disease progression and improve clinical outcomes. Regular medical monitoring is required during treatment due to possible side effects, including infections, bleeding risk, and changes in blood counts when used under strict specialist supervision and individualized treatment planning protocols.